Telix Pharmaceuticals Limited (ASX:TLX)

Telix Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 6, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Market Capitalization	5,110	3,794	8,238	3,263	2,300	2,209
Market Cap Growth	-18.50%	-53.95%	152.44%	41.89%	4.10%	108.44%
Enterprise Value	5,598	4,116	8,141	3,145	2,180	2,161
Last Close Price	15.04	11.20	24.61	10.08	7.27	7.75

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 6, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
PE Ratio	-	-	151.34	528.32	-	-
Forward PE	1266.75	282.12	87.27	32.83	-	-
PS Ratio	4.24	3.15	9.87	6.68	14.37	290.85
PB Ratio	8.21	6.09	14.44	21.66	28.75	1023.78
P/TBV Ratio	-	-	53.62	80.58	109.40	-
P/FCF Ratio	-	-	277.46	279.08	-	-
P/OCF Ratio	-	-	185.44	155.76	-	-
PEG Ratio	25.96	0.48	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 6, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	4.65	3.42	9.75	6.43	13.62	284.54
EV/EBITDA Ratio	92.80	84.57	84.48	56.13	-	-
EV/EBIT Ratio	193.60	142.34	90.15	61.25	-	-
EV/FCF Ratio	-	-	274.21	268.94	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 6, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	1.13	1.13	1.02	0.12	0.13	1.18
Debt / EBITDA Ratio	11.61	11.61	5.89	0.31	-	-
Debt / FCF Ratio	-	-	19.60	1.54	-	-
Net Debt / Equity Ratio	0.78	0.78	-0.23	-0.70	-1.32	-9.03
Net Debt / EBITDA Ratio	10.02	10.02	-1.34	-1.89	1.52	0.25
Net Debt / FCF Ratio	-7.57	-7.57	-4.34	-9.04	1.49	0.32
Asset Turnover	0.76	0.76	0.85	1.48	0.88	0.06
Inventory Turnover	13.90	13.90	10.84	14.01	10.92	1.25
Quick Ratio	1.21	1.21	2.63	1.20	1.90	1.13
Current Ratio	1.43	1.43	2.78	1.43	2.03	1.25
Return on Equity (ROE)	-1.85%	-1.85%	14.79%	5.36%	-253.34%	-198.36%
Return on Assets (ROA)	1.15%	1.15%	5.74%	9.69%	-25.37%	-37.95%
Return on Invested Capital (ROIC)	2.60%	3.81%	32.69%	537.03%	-	-
Return on Capital Employed (ROCE)	2.10%	2.10%	7.60%	21.10%	-43.60%	-113.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 6, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-0.21%	-0.28%	0.66%	0.19%	-4.53%	-3.64%
FCF Yield	-1.26%	-1.70%	0.36%	0.36%	-3.09%	-2.75%
Buyback Yield / Dilution	2.12%	2.12%	-6.64%	-4.21%	-10.08%	-9.69%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 7, 2026

Data Sources Report a data error